Topline SAFETY and EFFICACY results of recently completed Phase II study in Korea of Pyramax or Arpycom (a fixed dose combination of pyronaridine tetraphosphate and artesunate, hereafter referred to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results